Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone and Varenicline on Alcohol-Mediated Smoking Lapse
NCT00773422Phase 2Completed
- Sponsor
- Yale University
- Start
- Jan 2008
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone, varenicline in nicotine dependence, sponsored by Yale University. Started Jan 2008; status: completed.
02
Drugs
naltrexonevarenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00773422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00773422.